|
CN111757746A
|
|
Long-term CAR treatment of cancer
|
|
US2019247436A1
|
|
Methods and compositions for modifying genomic dna
|
|
US2018112235A1
|
|
Methods and compositions for modifying genomic dna
|
|
CN106687585A
|
|
Methods and compositions for modifying genomic dna
|
|
US2016053283A1
|
|
Methods and compositions for generating stable transfected cells
|
|
AU2011211362A1
|
|
Methods and devices related to a regulated flow electroporation chamber
|
|
CN102124102A
|
|
Methods for optimizing electroporation
|
|
WO2009126789A2
|
|
Engineering and delivery of therapeutic compositions of freshly isolated cells
|
|
US2007059833A1
|
|
Use of Nucleases to Improve Viability and Enhance Transgene Expression in Transfected Cells
|
|
WO2007021993A1
|
|
Helical electrode geometries for electroporation
|
|
WO2006063301A1
|
|
Genetically modified tumor cells as cancer vaccines
|
|
KR20070091163A
|
|
Computerized electroporation
|
|
US2006134067A1
|
|
Loading of cells with antigens by electroporation
|
|
CN102268425B
|
|
Methods and devices related to regulation flow electroporation chamber
|
|
EP1597390A2
|
|
Loading of cells with antigens by electroporation
|
|
AU2003277109A1
|
|
Apparatus and method for streaming electroporation
|
|
WO03018751A2
|
|
Apparatus and method for electroporation of biological samples
|
|
US7029916B2
|
|
Apparatus and method for flow electroporation of biological samples
|
|
US6773669B1
|
|
Flow electroporation chamber and method
|
|
AU3013600A
|
|
Flow electroporation chamber and method
|
